Regulus Therapeutics Inc. (RGLS) Operating Lease, Right-of-Use Asset USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Regulus Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2018 to 2024.
  • Regulus Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $1.33 M, a 30.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.33 M -$572 K -30.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.48 M -$562 K -27.6% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 $1.62 M -$553 K -25.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.76 M -$543 K -23.5% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.9 M -$534 K -21.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.04 M -$525 K -20.5% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $2.17 M -$516 K -19.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.31 M -$508 K -18.1% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.44 M -$533 K -18% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $2.56 M +$2.31 M +913% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $2.69 M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $2.81 M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $2.97 M Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $253 K -$211 K -45.5% Dec 31, 2020 10-K 2022-03-11
Q4 2019 $464 K -$2.84 M -85.9% Dec 31, 2019 10-K 2021-03-09
Q3 2019 $510 K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $0 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $0 Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $3.3 M Jan 1, 2019 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.